Prescribers should document their clinical rationale, including the absence of contraindications, in the patient's medical record
Overall, SANA appears to be a first-in-class activator of creatine-dependent energy expenditure and thermogenesis, highlighting its potential as a therapeutic candidate for diabesity
Las evidencias acumuladas en las ltimas dcadas respecto a la eficacia de los nuevos tratamientos farmacolgicos de la obesidad han convertido a la molcula del pptido anlogo al glucagn tipo1 (GLP-1) en un componente clave, ya sea en forma de monoagonistas, multiagonistas unimoleculares o combinaciones con efectos sobre diversos receptores1
PCOS (polycystic ovary syndrome) Metformin has been used for decades in PCOS management due to its effects on insulin resistance, which drives many PCOS symptoms
Seek Medical Supervision and Individualized GLP-1 Dosing Medical weight loss supervision is about optimizing your results
A compounding interest Going forward, the FDA will allow compounding of prescriptions specific to particular patients
